Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06332092 |
| Title | FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) |
| Acronym | HNSCC |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Fulgent Pharma LLC. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Highlands Oncology - North Hills | Fayetteville | Arkansas | 72703 | United States | Details | |
| USC/Norris Comprehensive Cancer Center and Hospital | Los Angeles | California | 90033 | United States | Details | |
| Moffitt Cancer Center Magnolia Campus | Tampa | Florida | 33612 | United States | Details | |
| Fort Wayne Medical Oncology and Hematology | Fort Wayne | Indiana | 46804 | United States | Details | |
| Texas Oncology - Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | United States | Details | |
| Texas Oncology - Northeast Texas Cancer & Research Institute | Tyler | Texas | 75702 | United States | Details |